These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 28930757)
21. Expression of chemokine receptors in human gastric cancer. Kwak MK; Hur K; Park DJ; Lee HJ; Lee HS; Kim WH; Lee KU; Choe KJ; Yang HK Tumour Biol; 2005; 26(2):65-70. PubMed ID: 15867478 [TBL] [Abstract][Full Text] [Related]
22. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer. Zeng Z; Chen X; Zhu D; Luo Z; Yang M Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980 [TBL] [Abstract][Full Text] [Related]
23. Positive lymph-node breast cancer patients – activation of NF-κB in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7. El-Ghonaimy EA; El-Shinawi M; Ibrahim SA; El-Ghazaly H; Abd-El-Tawab R; Nouh MA; El-Mamlouk T; Mohamed MM FEBS J; 2015 Jan; 282(2):271-82. PubMed ID: 25327843 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of CCR7 expression in gastric cancer. Ishigami S; Natsugoe S; Nakajo A; Tokuda K; Uenosono Y; Arigami T; Matsumoto M; Okumura H; Hokita S; Aikou T Hepatogastroenterology; 2007 Jun; 54(76):1025-8. PubMed ID: 17629031 [TBL] [Abstract][Full Text] [Related]
25. Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases. Strien L; Joensuu K; Heikkilä P; Leidenius MH Anticancer Res; 2017 Jan; 37(1):175-182. PubMed ID: 28011488 [TBL] [Abstract][Full Text] [Related]
26. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection. An S; Tiruthani K; Wang Y; Xu L; Hu M; Li J; Song W; Jiang H; Sun J; Liu R; Huang L Small; 2019 Mar; 15(9):e1805182. PubMed ID: 30690891 [TBL] [Abstract][Full Text] [Related]
27. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer. He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004 [TBL] [Abstract][Full Text] [Related]
28. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer]. Liu ZF; Chen C; Yao XL; Sun SR Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638 [TBL] [Abstract][Full Text] [Related]
29. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer. Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553 [TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic CCR7 (CCR7c) immunoexpression is associated with local tumor recurrence in triple-negative breast cancer. Gurgel DC; Wong DVT; Bandeira AM; Pereira JFB; Gomes-Filho JV; Pereira AC; Barros Silva PG; Távora FRF; Pereira AF; Lima-Júnior RCP; Almeida PRC Pathol Res Pract; 2020 Dec; 216(12):153265. PubMed ID: 33181406 [TBL] [Abstract][Full Text] [Related]
31. The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer. Huang SP; Liu PY; Kuo CJ; Chen CL; Lee WJ; Tsai YH; Lin YF J Hematol Oncol; 2017 Jun; 10(1):114. PubMed ID: 28576130 [TBL] [Abstract][Full Text] [Related]
32. CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer. Kwon MJ; Han J; Seo JH; Song K; Jeong HM; Choi JS; Kim YJ; Lee SH; Choi YL; Shin YK PLoS One; 2015; 10(10):e0139112. PubMed ID: 26444008 [TBL] [Abstract][Full Text] [Related]
33. Association of CXCR4, CCR7, VEGF-C and VEGF-D expression with lymph node metastasis in patients with cervical cancer. Dai Y; Tong R; Guo H; Yu T; Wang C Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():178-183. PubMed ID: 28535405 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889 [TBL] [Abstract][Full Text] [Related]
35. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. Shang ZJ; Liu K; Shao Z Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985 [TBL] [Abstract][Full Text] [Related]
36. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways. Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073 [TBL] [Abstract][Full Text] [Related]
37. Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases. Valla M; Mjønes PG; Engstrøm MJ; Ytterhus B; Bordin DL; van Loon B; Akslen LA; Vatten LJ; Opdahl S; Bofin AM J Histochem Cytochem; 2018 Nov; 66(11):787-799. PubMed ID: 30052477 [TBL] [Abstract][Full Text] [Related]
38. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer. Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701 [TBL] [Abstract][Full Text] [Related]
39. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients. Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125 [TBL] [Abstract][Full Text] [Related]
40. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray. Guo J; Gong G; Zhang B Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]